[O13] Oral Session 13　呼吸器3（希少な遺伝子変異）
【E】

[O13-2] Efficacy of sotorasib in KRAS p.G12C-mutated NSCLC with stable brain metastases: a post-hoc analysis of CodeBreaK 100

^○豊澤 亮¹, Suresh S. Ramalingam², Ferdinandos Skoulidis³, Ramaswamy Govindan⁴, Vamsidhar Velcheti⁵, Bob T. Li⁶, Benjamin Besse⁷, Grace K. Dy⁸, Dong-Wan Kim⁹, Martin Schuler¹⁰, Mark Vincent¹¹, Frederick Wilson¹², Joseph Park¹³, Juan E. Gutierrez¹⁴, Qui Tran¹³, Simon P. Jones¹³, Juergen Wolf¹⁵ (1.Division of Thoracic Oncology, National Hospital Organization Kyushu Cancer Center, 2.Winship Cancer Institute, Emory University School of Medicine, 3.University of Texas M.D. Anderson Cancer Center, 4.Alvin J. Siteman Cancer Center, Washington University School of Medicine, 5.Perlmutter Cancer Center, NYU Langone, 6.Memorial Sloan Kettering Cancer Center and Weill Cornell Medicine, 7.Gustave Roussy Institute, 8.Roswell Park Cancer Institute, 9.Seoul National University Hospital, 10.West German Cancer Center, University Hospital Essen, 11.London Regional Cancer Program, 12.Yale School of Medicine, 13.Amgen Inc, 14.Cedimed-Quiron Salud, 15.University Hospital Cologne)